Powder: -20°C for 3 years | In solvent: -80°C for 1 year
IAA65 is a potent inhibitor of T-type calcium channels, exhibiting an IC50 value of 18.9 μM, and holds potential for use in epilepsy research [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,520.00 | |
50 mg | 10-14 weeks | $ 1,980.00 | |
100 mg | 10-14 weeks | $ 2,500.00 |
Description | IAA65 is a potent inhibitor of T-type calcium channels, exhibiting an IC50 value of 18.9 μM, and holds potential for use in epilepsy research [1]. |
In vitro | IAA65 at a concentration of 50 μM in differentiated ND7/23 cells notably decreases the current density produced through the activation of T-type Ca 2+ channels and modifies the steady-state inactivation of Cav3.2 and Cav3.3 T-type Ca 2+ channels. This modification significantly prolongs the channels' recovery time from inactivation [1]. |
Molecular Weight | 365.27 |
Formula | C16H13F6NO2 |
CAS No. | 2987139-96-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
IAA65 2987139-96-6 inhibitor inhibit